About Sequenom
Sequenom is a company based in San Diego (United States) founded in 1994 was acquired by LabCorp in July 2016. Sequenom has completed 1 acquisition, including Sensigen. Sequenom offers products and services including Genetic Testing, At-Home Kits, and Clinical Trial Testing. Sequenom operates in a competitive market with competitors including Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sequenom, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sequenom
Sequenom offers a comprehensive portfolio of products and services, including Genetic Testing, At-Home Kits, and Clinical Trial Testing.
Services for hereditary disease detection and analysis
Kits for self-collection and remote diagnostic testing
Testing support for biopharma and medical research
Funding Insights of Sequenom
Investors in Sequenom
Sequenom has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for Sequenom
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sequenom
Sequenom has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sensigen.
Investment portfolio details for Sequenom
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Women's health and genetic testing services are provided with support.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Sequenom
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sequenom
Detailed financials for Sequenom
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sequenom Comparisons
Peer comparison for Sequenom
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sequenom
Sequenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
Detailed competitors of Sequenom
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sequenom
Complete news archive for Sequenom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sequenom
Sequenom was founded in 1994 and raised its 1st funding round 9 years after it was founded.
Sequenom is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Sequenom was established in 1994 in San Diego, United States, within the biotechnology sector. Noninvasive prenatal testing is delivered through circulating cell-free fetal nucleic acids. Laboratory-developed tests for prenatal diseases and conditions are developed and commercialized. Operations center on genetic diagnostics in healthcare, with services targeted at prenatal screening needs across the region.
Sequenom's top competitors include Natera, BillionToOne and Pictor.
Sequenom offers Genetic Testing, At-Home Kits, and Clinical Trial Testing.
Sequenom has made 1 acquisition, including Sensigen.
Sequenom has 1 investor. Key investors include LabCorp.